ESR1 and breast cancer: Accordingly, loss of ER expression or cell‐cell junctions, undergoing EMT process and increased BCSC cells occur in TAM resistant tumours.5, 24, 25 In this study, we found a down‐regulated DLG5 expression in TAM‐resistant breast cancer tissues and cells.